EUVIMEDEUVIMED entdecken
Crossref

Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates

Nadia Fida iD, Todd N Eagar, Allison N Yun, Alex W Rogers, Duc T Nguyen iD, Edward A Graviss, Farhan Ishaq, Nicholas R DiPaola, Ju Kim, Gorthi Janardhana, Mahwash Kassi, Rayan Yousefzai und 4 weitere

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Nadia Fida und 15 weiteren Autor:innen. Beteiligte Einrichtung: Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Plasma Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Desensitization is one of the strategies to reduce antibodies and facilitate heart transplantation in highly sensitized patients. We describe our center's desensitization experience with combination of plasma cell (PC) depletion therapy (with proteasome inhibitor or daratumumab) and costimulation blockade (with belatacept).

Methods

We reviewed five highly sensitized patients who underwent desensitization therapy with plasma cell depletion and costimulation blockade. We evaluated the response to therapy by measuring the changes in cPRA, average MFI, and number of positive beads > 5000MFI.

Results

Five patients, mean age of 56 (37‐66) years with average cPRA of 98% at 5000 MFI underwent desensitization therapy. After desensitization, mean cPRA decreased from 98% to 70% ( p = .09), average number of beads > 5000 MFI decreased from 59 to 37 ( p = .15), and average MFI of beads > 5000 MFI decreased from 16713 to 13074 ( p = .26).

Conclusion

Combined PC depletion and CoB could be a reasonable strategy for sustained reduction in antibodies in highly sensitized patients being listed for heart transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationPlasma CellsHumansMiddle AgedAbataceptDesensitization, ImmunologicGraft RejectionHLA AntigensIsoantibodiesProteasome InhibitorsAdultAged

Stichwörter der Autor:innen

cell therapycostimulation blockadedesensitizationheart transplant

Substanzen

AbataceptHLA AntigensIsoantibodiesProteasome Inhibitors

Autor:innen und Institutionen

  • Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA.
  • Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.
  • Department of Pharmacy, Houston Methodist Hospital, Houston, Texas, USA.
  • Department of Pathology and Genomic Medicine, Institute for Academic Medicine, Houston Methodist Research Institute, Houston, Texas, USA.

ORCID-Profile: Nadia Fida, Duc T Nguyen

Zitieren

APA

Fida, N., Eagar, T. N., Yun, A. N., Rogers, A. W., Nguyen, D. T., Graviss, E. A., Ishaq, F., DiPaola, N. R., Kim, J., Janardhana, G., Kassi, M., Yousefzai, R., Suarez, E. E., Bhimaraj, A., Krisl, J. C., & Guha, A. (2024). Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates. Clinical Transplantation. https://doi.org/10.1111/ctr.15249

Vancouver

Fida N, Eagar TN, Yun AN, Rogers AW, Nguyen DT, Graviss EA, et al. Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates. Clinical Transplantation. 2024. doi:10.1111/ctr.15249

BibTeX
@article{Fida2024,
  author = {Fida, Nadia and Eagar, Todd N and Yun, Allison N and Rogers, Alex W and Nguyen, Duc T and Graviss, Edward A and Ishaq, Farhan and DiPaola, Nicholas R and Kim, Ju and Janardhana, Gorthi and Kassi, Mahwash and Yousefzai, Rayan and Suarez, Eric E and Bhimaraj, Arvind and Krisl, Jill C and Guha, Ashrith},
  title = {Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15249}
}
Kostenlos starten →